BioSig Technologies CEO Interview: Disruptive Technology in Rapidly Growing $4B EP Market

A recent interview on ceolive.tv featured BioSig Technologies (OTCQB:BSGM) President and CEO Gregory Cash who discussed the developing a proprietary technology platform designed to improve the rapidly growing multi-billion dollar electrophysiology (EP) marketplace.
Watch the full interview:

Connect with BioSig Technologies (OTCQB:BSGM) to receive an Investor Presentation.